Olga Andrievskaia

Dr. Olga Andrievskaia

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in Analytical Biochemistry
Verified
Journal Article
Closed access
CMClaudia Avis Madampage
Claudia Avis Madampage
OAOlga Andrievskaia
Olga Andrievskaia
JLJeremy S. Lee
Jeremy S. Lee

1 July 2013 in Prion
Verified
Journal Article
Open access
PDF file
CMClaudia A Madampage
Claudia A Madampage
PMPekka Määttänen
Pekka Määttänen
KMKristen Marciniuk
Kristen Marciniuk
RBRobert Brownlie
Robert Brownlie
OAOlga Andrievskaia
Olga Andrievskaia
SNScott Napper
Scott Napper
Transmissible spongiform encephalopathies (TSEs) are fatal neurodegenerative diseases that are based on the misfolding of a cellular prion protein (PrPC) into an infectious, pathological conformation (PrPSc). There is proof-of-principle evidence that a prion vaccine is possible but this is tempered with concerns of the potential dangers associated with induction of immune responses to a widely-expressed self-protein. By targeting epitopes that are specifically exposed upon protein misfolding, our group developed a vaccine that induces PrPSc-specific antibody responses. Here we consider the ability of this polyclonal antibody (SN6b) to bind to a mutant of PrPC associated with spontaneous prion disease. Polyclonal antibodies were selected to mimic the vaccination outcome and also explore all possible protein conformations of the recombinant bovine prion protein with mutation T194A [bPrP(T194A)]. This mutant is a homolog of the human T183A mutation of PrPC that is associated with early onset of familial dementia. With nanopore analysis, under non-denaturing conditions, we observed binding of the SN6b antibody to bPrP(T194A). This interaction was confirmed through ELISAs as well as immunoprecipitation of the recombinant and cellularly expressed forms of bPrP(T194A). This interaction did not promote formation of a protease resistant conformation of PrP in vitro. Collectively, these findings support the disease-specific approach for immunotherapy of prion diseases but also suggest that the concept of conformation-specific immunotherapy may be complicated in individuals who are genetically predisposed to PrPC misfolding.

1 February 2018 in Veterinary Microbiology
Verified
Journal Article
Closed access
OAOlga Andrievskaia
Olga Andrievskaia
CTClaude Turcotte
Claude Turcotte
GBGloria Berlie-Surujballi
Gloria Berlie-Surujballi
HBHannah Battaion
Hannah Battaion
DLDara Lloyd
Dara Lloyd

12 April 2018 in Microbiology Resource Announcements
Verified
Journal Article
Open access
OAOlga Andrievskaia
Olga Andrievskaia
MDMarc-Olivier Duceppe
Marc-Olivier Duceppe
DLDara Lloyd
Dara Lloyd
Mycobacterium bovis is the causative agent of bovine tuberculosis, an infectious disease that affects both animals and humans and thus presents a risk to public health and the livestock industry. Here, we report the genome sequences of five Mycobacterium bovis strains that represent major genotype clusters observed in farmed animals and wildlife in Canada.

1 December 2014 in Journal of Food Protection
Verified
Journal Article
Closed access
OAOlga Andrievskaia
Olga Andrievskaia
ETErin Tangorra
Erin Tangorra
Contamination of rendered animal byproducts with central nervous system tissues (CNST) from animals with bovine spongiform encephalopathy is considered one of the vehicles of disease transmission. Removal from the animal feed chain of CNST originated from cattle of a specified age category, species-labeling of rendered meat products, and testing of rendered products for bovine CNST are tasks associated with the epidemiological control of bovine spongiform encephalopathy. A single-step TaqMan real-time reverse transcriptase (RRT) PCR assay was developed and evaluated for specific detection of bovine glial fibrillary acidic protein (GFAP) mRNA, a biomarker of bovine CNST, in rendered animal by-products. An internal amplification control, mammalian b -actin mRNA, was coamplified in the duplex RRT-PCR assay to monitor amplification efficiency, normalize amplification signals, and avoid false-negative results. The functionality of the GFAP mRNA RRT-PCR was assessed through analysis of laboratory-generated binary mixtures of bovine central nervous system (CNS) and muscle tissues treated under various thermal settings imitating industrial conditions. The assay was able to detect as low as 0.05 % (wt/wt) bovine brain tissue in binary mixtures heat treated at 110 to 130°C for 20 to 60 min. Further evaluation of the GFAP mRNA RRT-PCR assay involved samples of industrial rendered products of various species origin and composition obtained from commercial sources and rendering plants. Low amounts of bovine GFAP mRNA were detected in several bovine-rendered products, which was in agreement with declared species composition. An accurate estimation of CNS tissue content in industrial-rendered products was complicated due to a wide range of temperature and time settings in rendering protocols. Nevertheless, the GFAP mRNA RRT-PCR assay may be considered for bovine CNS tissue detection in rendered products in combination with other available tools (for example, animal age verification) in inspection programs.

16 March 2023 in Microbiology Resource Announcements
Verified
Journal Article
Open access
OAOlga Andrievskaia
Olga Andrievskaia
AGAmalia Garceac
Amalia Garceac
DLDara Lloyd
Dara Lloyd
MSMirjana Savic
Mirjana Savic
MDMarc-Olivier Duceppe
Marc-Olivier Duceppe
Mycobacterium bovis is the primary causative agent of bovine tuberculosis, a zoonotic infectious disease that presents a risk to public health, livestock, and wildlife. Here, we report complete genome sequences of two Mycobacterium bovis strains affiliated with bovine tuberculosis outbreaks in Canadian cattle farms in 2016 and 2018.